Solenoid Valve Market Aims for US$ 6.9 Billion by 2033 – Insights by Future Market Insights

The solenoid valve market is forecast to expand at 4.5% CAGR over the estimated time, as per FMI’s analysis. The industry’s size is predicted to reach a market value of US$ 4.5 billion in 2023.

Strict regulations in the food and beverage and medical industries, especially in developed countries, are propelling the demand for solenoid valves in their production process. Additionally, today’s technology-driven environment is giving momentum to automation in several industries. Since the increase in industries requiring power is rising, governments are coming forward to boost the capacity of the prevailing power plants and have sanctioned projects to build new power plants.

Surging concerns over the plants’ safety magnify the solenoid valve’s prospects. Owing to their strong magnetic field and electric current, solenoid valve makes for a great safety measure to debilitate the effect of a potential disaster.

Request For Sample Report: Elevate Your Industry Intelligence with Actionable Insights
https://www.futuremarketinsights.com/reports/sample/rep-gb-17425

Key players in the market are making significant investments in research activities to expand their product lines. Locally increasing the manufacturing capacity also helps reduce the company’s operational costs. Key manufacturers are employing this business tactic to help increase their overall revenue.

Key Takeaways From the Solenoid Valve Market Report:

  • The United States industry is projected to reach US$ 2.2 billion by 2033. From 2023 to 2033, the market is expected to record a CAGR of 3.4%.
  • The United Kingdom solenoid valve industry is expected to reach US$ 347.2 million by 2033 end. In the coming decade, the industry is anticipated to perceive a market CAGR of 3.7%, in contrast to the 4.3% CAGR observed in the historical period.
  • The China solenoid valve industry is expected to expand at a CAGR of 5.4% to reach US$ 595.5 million by 2033. In the historical period, the market recorded a CAGR of 6.9%.
  • The Japan solenoid valve industry is projected to gain US$ 503.1 million by 2033. Over the forthcoming period, the market is anticipated to expand at a CAGR of 3.9%, as opposed to a 4.7% CAGR in the historical period.
  • The South Korea solenoid valve industry is estimated to expand at a CAGR of 4.9% compared to the 6.2% CAGR observed in the historical period. By 2033, the market is projected to reach US$ 280.6 million 2033.
  • Based on operation, the normally open segment is projected to expand at a CAGR of 4.4% over the forecast period. In the historical period, the segment registered a CAGR of 5.2%.
  • Based on function, the 2-way segment is projected to represent a CAGR of 4.3% in the next ten years. In the historical period, the market registered a CAGR of 5%.

Competitive Landscape:

  • Kendrion exhibited its newly developed bistable solenoid valve 63.0 in October 2022 at COMPAMED 2022. The valve regulates the rate of flow. A joined permanent magnet ensures it is de-energized in the closed or open state without permanently energizing the coil. The valve is commercially available in a 3/2- or 2/2-way version and can be tailored to meet precise requirements.
  • Emerson, an engineering, technology, and software firm, began operations in Mahindra World City, Chennai, in February 2022. This unit develops pneumatics and fluid control products, such as cylinders, solenoid valves, pneumatic valves and manifolds, air preparation units, etc., for Emerson’s field-proven brands ASCO, AVENTICS, TESCOM, and TopWorx.

Key Companies Profiled:

  • Airtac
  • ASCO Valve Inc.
  • Danfoss Industries Limited
  • Curtiss-Wright Corporation
  • IMI Precision Engineering
  • Emerson Electric Co.
  • Juliang Valve
  • Parker Hannifin Corporation
  • Zhejiang Yongjiu
  • SMC Corporation

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights
https://www.futuremarketinsights.com/checkout/17425

Key Segments Profiled:

By Type:

  • Direct-acting Valves
  • Pilot-operated Valves

By Function:

  • 2-way
  • 3-way
  • 4-way
  • 5-way

By Material:

  • Stainless Steel
  • Aluminum
  • Plastic
  • Others

By Operation:

  • Normally Open
  • Normally Closed
  • Universal

By Media:

  • Air
  • Gas
  • Water

By Industry:

  • Oil & Gas
  • Chemical & Petrochemical
  • F&B
  • Power Generation
  • Pharmaceuticals
  • Automotive
  • Medical
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Global DNA Methylation Market, driven by progress in molecular imprints, is expected to hit US$ 5815.49 million by 2033

DNA Methylation Market
DNA Methylation Market

The global DNA methylation market demand is anticipated to reach a market size of US$ 1437.5 Million in 2023 and US$ 5815.49 Million by 2033, showing a CAGR of 15% during that time. The biggest factor expected to contribute to the DNA Methylation Industry’s expected rise is the rising incidence of cancer worldwide. From 2016 to 2021, the market for DNA methylation experienced a CAGR of 11%.

The DNA Methylation Industry has gained significant attention in recent years due to its potential applications in various fields, including medical research, diagnostics, and personalized medicine. DNA methylation is an epigenetic modification that plays a crucial role in gene regulation, and aberrant DNA methylation patterns have been linked to numerous diseases, such as cancer, neurological disorders, and autoimmune conditions. As a result, the demand for DNA methylation analysis tools and services has been steadily increasing, driving the growth of the DNA Methylation Industry.

Request A Sample Copy Of This Research Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-15893

One of the primary factors contributing to the expansion of the DNA Methylation Industry is the growing understanding of the role of DNA methylation in disease development and progression. Researchers and clinicians have recognized the significance of DNA methylation as a potential biomarker for early detection, prognosis, and treatment response prediction. By analyzing the DNA methylation patterns, scientists can gain insights into the molecular mechanisms underlying diseases and develop targeted therapies accordingly.

Moreover, technological advancements have propelled the DNA Methylation Industry forward. High-throughput sequencing technologies, such as next-generation sequencing (NGS), have revolutionized DNA methylation analysis by enabling the simultaneous investigation of the entire genome. These advanced techniques provide researchers with unprecedented resolution and accuracy, allowing them to identify specific DNA methylation changes associated with different diseases. The development of cost-effective and user-friendly DNA methylation analysis platforms has also contributed to the widespread adoption of DNA methylation analysis in both research and clinical settings.

Key Takeaways from the Market Study:

  • By technology, sequencing is expected to possess 35% market share for DNA Methylation Industry in 2023.
  • By product, consumables are expected to possess 35% market share for DNA Methylation Industry in 2023.
  • By application, clinical research is expected to possess 40% market share for DNA Methylation Industry in 2023.
  • By application, diagnostic segment is anticipated to witness the fastest growth in the coming years with a CAGR of 16%.
  • By end use, pharmaceutical and biotechnology end-use segment are expected to possess 42% market share for DNA methylation in 2023.
  • North America is expected to possess 40% market share for DNA Methylation Industry in 2023.
  • Asia Pacific is expected to possess 38% market share for DNA Methylation Industry in 2023.

“Expenditure on research and development along with government funding is expected to accelerate the growth of DNA Methylation Industry. comments a Future Market Insights analyst.

See Beyond The Ordinary With Our Extraordinary Methodology Insights: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15893

Competitive Landscape:

Some prominent players in the global DNA Methylation Industry include

  • New England Biolabs
  • Sysmex Corporation
  • Abcam plc.
  • F. Hoffmann-La Roche Ltd.
  • Diagenode Diagnostics S.A.
  • Thermo-Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • BioRad Laboratories Inc.
  • Exact Sciences Corporation
  • QIAGEN N.V.
  • Active Motif, Inc.
  • Illumina Inc.
  • EpiGentek Group Inc.

In May 2022, Oxford Nanopore announced integrating Remora, a technique that offers accurate and real-time epigenetic insights with nanopore sequencing software. This would further offer simple access to accurate whole genome methylation detection.

In June 2020, Base Genomics announced of advancing and developing its DNA methylation technology. the aim is to sequence a large amount of epigenetic data from a blood test which could revolutionize the preventative medicine arena.

Unlock Exclusive Market Segments Insights: Buy Now: https://www.futuremarketinsights.com/checkout/15893

Key Segments Profiled in the DNA Methylation Industry Survey:

Technology:

  • Polymerase Chain Reaction (PCR)
  • Microarray
  • Sequencing
  • Others

Product:

  • Consumables
  • Kits & Reagents
  • Enzymes
  • Instruments & Software

Application:

  • Gene Therapy
  • Clinical Research
  • Diagnostics
  • Others

End-use:

  • Hospital & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research & Academia

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Osmotic Pumps Market Set for Healthy 9% CAGR Growth from 2022 to 2032

The global osmotic pumps market is poised for significant expansion, forecasted to achieve a healthy Compound Annual Growth Rate (CAGR) of 9% between 2022 and 2032, securing a substantial market share.

Key drivers fueling this growth include the emergence of new manufacturers and remarkable technological advancements within the osmotic pumps sector. As the market continues to evolve, innovative solutions and increased competition are reshaping the landscape, driving forward momentum and enhancing product offerings.

Osmotic pumps, known for their controlled drug delivery capabilities, are witnessing heightened demand across various healthcare applications. Their ability to provide precise and sustained drug release over extended periods makes them indispensable in the treatment of chronic conditions and the management of patient care.

Furthermore, advancements in manufacturing techniques and materials are enhancing the efficiency and reliability of osmotic pumps, contributing to their widespread adoption in the pharmaceutical and healthcare industries. These developments not only improve patient outcomes but also offer new opportunities for market expansion and innovation.

The forecasted 9% CAGR reflects the growing demand for osmotic pumps globally and underscores their increasing importance in modern healthcare. As the market continues to thrive, stakeholders are urged to stay abreast of evolving trends and capitalize on emerging opportunities to drive growth and innovation.

Key Segments Profiled in the Osmotic Pumps Market Survey

By Product Type:

  • Oral Osmotic Pump
  • Implantable Osmotic Pump

By End Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinic
  • Homecare Setting

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Global Medical Biomimetics Market is poised to reach US$ 63.15 Billion by 2033, according to FMI analysis

Medical Biomimetics Market
Medical Biomimetics Market

The global medical biomimetics market size continues to surge, reaching a market value of US$ 32.10 Billion in 2023 and poised to scale further heights, projected to accumulate a market value of US$ 63.15 Billion by 2033. These insights come from a comprehensive study conducted by leading research experts, shedding light on the industry’s growth trajectory and its driving forces.

The projected Compound Annual Growth Rate (CAGR) of 7% between 2023 and 2033 underscores the market’s robust expansion. This momentum is propelled by several key factors, notably the substantial increase in government funding allocated to biomimetics research initiatives. Additionally, the widespread adoption and continuous innovations in medical engineering and nanotechnology within the healthcare sector contribute significantly to this growth.

Request A Sample Copy of This Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-15894

As such, there exists an unmet need, the research and development activities are being carried out for affordable and long-lasting solutions for pathology, injury, and corneal blindness. For instance, in March 2022, researchers from the Centre for LV Prasad Eye Institute, IIT-Hyderabad and Cellular, and Molecular Biology developed an exclusive biomimetic corneal hydrogel, manufactured from discarded human corneas, which can be used for the treatment of corneal scarring, the main cause of corneal blindness.

Furthermore, with the escalating number of accidents, the implementation of biomimetics for orthopaedics is projected to boom. According to Association for Safe International Road Travel, every year about 20 to 50 million people worldwide suffer from injuries that leads to permanent disability. Hence, such factors are estimated to impact positively the growth of the medical biomimetics industry.

Key Takeaways from the Market Study:

  • By product, cardiovascular segment is expected to possess 43% market share for medical biomimetics industry in 2023
  • By application, the wound healing segment is expected to dominate the medical biomimetics industry and expected to account for 35% market share in 2023
  • North America is expected to possess 40% market share for medical biomimetics industry in 2023
  • Asia Pacific is expected to possess 36% market share for medical biomimetics industry in 2023

“The increasing prevalence of diseases along with development of technologically advanced equipment is contributing to medical biomimetics industry,” comments a Future Market Insights analyst.

Unlock A Wealth Of Knowledge With Our Methodology Insights Now: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15894

Competitive Landscape:

Some of the key players in the global medical biomimetics industry include:

  • Otsuka Medical Devices Group
  • Stryker
  • Abbott
  • AVINENT Science and Technology
  • SynTouch Inc.
  • Osteopore International Pte Ltd
  • Vandstrom, Inc.
  • Biomimetics Technologies Inc
  • Swedish Biomimetics 3000 ApS
  • Keystone Dental Group
  • LifeMatrix
  • Curasan, Inc.
  • CorNeat Vision

Numerous companies in the medical biomimetics industry are expanding their products in emerging markets.

  • In November 2021, Osteopore has been granted a patent in China for its smart 3D biometric scaffolds. The technology was developed with scientists from NTU Singapore and was previously granted a European patent in early 2021. This patent is anticipated to create numerous research and development opportunities in the Chinese market and allows the company to tap into local expertise as part of its product advancement process.
  • In April 2021, Curasan AG expanded its distribution network in Europe, the company has added Silesia Dental and Implants Diffusion International SARL to its European distribution network.

Seize this Opportunity for Detailed Market Intel: Purchase Now to Access: https://www.futuremarketinsights.com/checkout/15894

Key Segments Profiled in the Medical Biomimetics Industry Survey:

Type:

  • Cardiovascular
  • Orthopaedic
  • Ophthalmology
  • Dental
  • Others

Application:

  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Other Applications

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Orthopedic Consumables Market Gears Up for Consistent 3% CAGR Growth from 2022 to 2032

Orthopedic Consumables Market
Orthopedic Consumables Market

The global orthopaedic consumables market sales is expected to grow at a compound annual growth rate (CAGR) of 3% between 2022 and 2032, with revenues expected to increase from US$ 41 billion in 2022 to US$ 55 billion.The market for orthopaedic consumables is expanding at a significant rate at the moment due to a persistent need for goods necessary for orthopaedic surgeries and treatments. This market includes a wide variety of consumables that are essential for orthopaedic procedures, such as surgical equipment, implants, and other medical devices. The ageing of the population, the development of orthopaedic technology, and the rise in musculoskeletal problems are all factors driving the market’s growth. Stakeholders in the market are anticipated to concentrate on innovation, research, and development as orthopaedic care gets more individualised and complex in order to meet the changing demands of orthopaedic physicians and other medical professionals. The global success and general efficacy of orthopaedic therapies are greatly aided by the orthopaedic consumables market.

The Orthopedic consumables are unique solutions for assisting in orthopaedic surgeries facilitate the procedure endlessly. The consumable devices provide valuable assist in the application of various fillers and cement’s for optimum delivery of the orthopedic fillers, cements, and rods.
Widespread of the joint related disorders and orthopedic injuries related inconvenience is anticipated to surge the demand for knee related orthopedic consumables and further increase the demand for the orthopedic consumables market.

Orthopedic Consumables Market: Introduction
The Orthopedic consumables manufacturer are readily adoption to the low cost oriented solutions to optimize the manufacturing process and offer efficient customized solution to the Users. The Orthopedic consumables are solutions used in the treatment of orthopedic injuries and damages to the bone.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9663

The consumables include saw blade, k-wire, burrs, drill bits, and pins the rapidly growing patient pool with accidental injuries of upper extremity and lower extremity body parts. Additionally the sports related injuries involving the peripheral bone damages require critical treatment procedure and termed by using orthopedic consumables. The Orthopedic consumables is one of the essential category in the surgical planning of the orthopedic procedure.

Orthopedic consumables Market: Drivers and Restraints
The significant factor fueling the growth of Orthopedic consumables is rising prevalence of the accidental injuries, spinal deformities, arthritis, sports related injuries, resulting in hefty demand for Orthopedic consumables. Rising incidence of the lower and upper extremity related injuries is further anticipated to fuel the demand for the orthopedic consumables. Considering the higher adoption in sports related injuries.
As per the data from center for disease control and prevention (CDC) approximately 23% of the adults populating physician diagnosed arthritis and joint disorder with comparative higher prevalence rate in the female population of 24% as compared to male 19% in year 2016.

Orthopedic Consumables Market: Introduction
The Orthopedic consumables manufacturer are readily adoption to the low cost oriented solutions to optimize the manufacturing process and offer efficient customized solution to the Users. The Orthopedic consumables are solutions used in the treatment of orthopedic injuries and damages to the bone.
The consumables include saw blade, k-wire, burrs, drill bits, and pins the rapidly growing patient pool with accidental injuries of upper extremity and lower extremity body parts. Additionally the sports related injuries involving the peripheral bone damages require critical treatment procedure and termed by using orthopedic consumables. The Orthopedic consumables is one of the essential category in the surgical planning of the orthopedic procedure.

Orthopedic consumables Market: Drivers and Restraints
The significant factor fueling the growth of Orthopedic consumables is rising prevalence of the accidental injuries, spinal deformities, arthritis, sports related injuries, resulting in hefty demand for Orthopedic consumables. Rising incidence of the lower and upper extremity related injuries is further anticipated to fuel the demand for the orthopedic consumables. Considering the higher adoption in sports related injuries.
As per the data from center for disease control and prevention (CDC) approximately 23% of the adults populating physician diagnosed arthritis and joint disorder with comparative higher prevalence rate in the female population of 24% as compared to male 19% in year 2016.

High preferences for the singles use solution integrating higher safety profiles and convince is anticipated to lure new entreats in the orthopedic consumables market. However, the higher coast associate with orthopedic consumables is anticipated to restrain the growth of the orthopedic consumables Market.

Orthopedic consumables Market: Overview
The Orthopedic consumables market exhibits similar to perfect competition nature. Key players in the orthopedic consumables market are largely working on providing solution for offering high degree of safety profile and comfort.
The manufactures are accessing the latest technological trends to integrate the leading technological feature in orthopedic consumables to enable the user maximum satisfaction and enhanced mobility for the body parts. The growing incidence of the orthopedic fracture and dislocation is anticipated to fuel the demand for orthopaedics surgery and interventions and Thereby anticipated to offer new growth opportunity for the orthopedic consumables market.

The orthopedic consumables are also utilized in the interventional diagnosis and assessment of the orthopedic complications, similarly growing trend in the utilization of the orthopedic consumables in the join and hip replacement is anticipated to create new growth pockets in the market.
Furthermore advanced clinical usability offered by the devices is anointed to offer leverage in the safety profiles of the recovery process adopted physicians is anticipated to create significant demand for the orthopedic consumables market.

Orthopedic consumables Market: Region-Wise Overview
The Global Orthopedic consumables market is segmented into the following regions – North America, Latin America, Europe, East Asia, South Asia, Oceania and the Middle East & Africa. North America holds significant regional market for orthopedic consumables due to growing adoption of the orthopedic surgeries, primarily interventional surgery, reasoning to the advance management of the orthopedic in the region.
In East Asia, China is dominating Orthopedic consumables market due to widespread use of Orthopedic consumables additionally presence of local manufacturing facilities. Latin America Orthopedic consumables market is anticipated to show inferior growth rate owing to use of traditional remedies and low rate of treatment seeking rate.
South Asia is expected to grow at significantly higher growth rate due to increasing adoption of disposable devices and systems in developing countries like India. Growth in Middle East and Africa is considerably low due to lower penetrating of the market players in the regions.

Orthopedic consumables Market: Key Participants
Examples of some of the key participants in the orthopedic consumables market are ConMed Corporation Stryker Corporation, Johnson & Johnson,Zimmer Biomet, Medtronic plc, 3M Company, DSM Biomedical, Wright Medical Group, Inc., BioTek Instruments, Inc. Among others.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-9663

Key Segments:

By Product Type:

  • Wound-Management Orthopedic Consumables
  • Surgical Orthopedic Consumables
  • Others

By End Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Others

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Global Neurology Clinical Trials Market is anticipated to reach US$ 10.5 billion by 2032, driven by significant efforts to combat Huntington’s disease

Neurology Clinical Trials Market
Neurology Clinical Trials Market

The global neurology clinical trials market size is expected to grow from US$ 5.7 billion in 2022 to US$ 10.5 billion by 2032, at a CAGR of 6.3%. The growth of the market is attributed to the rising prevalence of neurological disorders, an aging population, and technological advancements. As per the findings, the neurology clinical trials market for Huntington’s disease achieved a growth rate of 5.2% during 2017-2021. Huntington’s disease occurs in every 2.7 per 100,000 habitats worldwide. Egypt contributes to the highest number of people suffering from Huntington’s disease with 21 of every 100,000 individuals.

Neurological disorders are a group of diseases that affect the brain, spinal cord, and nerves. Some of the most common neurological disorders include Alzheimer’s disease, Parkinson’s disease, stroke, multiple sclerosis, and epilepsy. The prevalence of neurological disorders is increasing worldwide, due to the aging population and changing lifestyles.

Get your Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-15859

The aging population is a major driver of the neurology clinical trials market. As people age, they are more likely to develop neurological disorders. For example, the risk of developing Alzheimer’s disease doubles every five years after age 65.

Technological advancements are also driving the growth of the neurology clinical trials market. New technologies, such as artificial intelligence (AI) and machine learning (ML), are being used to develop new drugs and treatments for neurological disorders. AI and ML are also being used to improve the efficiency and accuracy of clinical trials.

Key takeaways:

  • The global neurology clinical trials market is expected to grow at a CAGR of 6.3% from 2022 to 2032.
  • The growth of the market is attributed to the rising prevalence of neurological disorders, an aging population, and technological advancements.
  • The phase II segment is expected to account for the largest share of the neurology clinical trials market during the forecast period.
  • The Alzheimer’s disease segment is expected to account for the largest share of the neurology clinical trials market during the forecast period.
  • The interventional study design segment is expected to account for the largest share of the neurology clinical trials market during the forecast period.
  • North America is expected to account for the largest share of the neurology clinical trials market during the forecast period.

Unlock A Wealth Of Knowledge With Our Methodology Insights Now: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15859

US to dominate the neurology clinical trials Market throughout the Analysis Period:

The US generated the highest revenue in the neurology clinical trials market in 2021.  Revenue through neurology clinical trials in the U.S. grew at a CAGR of 5.3% during 2017-2021. An increase in life expectancy and a rise in neurological disorders in the U.S. is driving the need to expand neurology clinical trials. Support from government agencies and leading pharmaceutical companies like Biogen are leading the market with anticipated revenue growth of 6.6% CAGR over the forecasted period set between 2021 and 2032.

Neurology Clinical Trials Market: Competition Insights:

At present, health organizations and pharmaceutical companies are largely aiming at expanding their manufacturing facilities, investing in R&D, and inventing new drugs for the treatment of neurological disorders. The key companies operating in the neurology clinical trials market include

  • IQVIA
  • Novartis
  • Covance
  • Medpace
  • Charles River Laboratories
  • GlaxoSmithKline
  • Aurora Healthcare
  • Biogen

Some of the recent developments by key providers of neurology clinical trials are as follows:

  • In June 2022, Novartis announced the publication of Nature Medicine of Zolgensma data. The data revealed that children with spinal muscular atrophy (SMA) treated with Zolgensma were able to retain age-appropriate motor skills such as sitting, standing, and walking independently.
  • In June 2022, Biogen joined hands with Alectos Therapeutics to develop and commercialize a small molecule therapy known as AL01811, as a possible treatment for Parkinson’s disease. The collaboration will benefit Alectos with US$ 77.5 and US$ 630 Mn for development and commercial payments respectively. Moreover, Biogen will conduct responsible for regulatory costs and manufacturing once the therapy is approved for clinical settings.
  • In June 2022, Scientists at Yale University discovered that a drug developed by Bristol Myers Squibb has the ability to repair the loss of neuronal nexus known as synapse which is the key contributor to cognitive decline. The study also stated that it has the ability to restore synaptic connections in Alzheimer’s mouse models. The drug also minimized the toxic build-up of tau protein present in the brain of animals.
  • In April 2022, Novartis announced long-term data of Phase 3 ASCLEPIOS I/II trials. The data exhibited the efficacy of Kesimpta and stated that treatment of four years will reduce the risk of three and six months of confirmed disability and fewer relapses.
  • In April 2022, FDA granted Novartis, a commercial license to manufacture Zolgensma, a multi-product gene therapy with a 170,000 square-foot facility at Durham, N.C. site to test and release Zolgensma.

Act Now to Explore In-Depth Market Analysis: Get Exclusive Purchase Now to Access! https://www.futuremarketinsights.com/checkout/15859

Key Segments Covered in Neurology Clinical Trials Industry Survey:

Neurology Clinical Trials Market by Phase:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Neurology Clinical Trials Market by Study Design:

  • Interventional
  • Observational
  • Expanded access

Neurology Clinical Trials Market by Indication:

  • Epilepsy
  • Parkinson’s Disease
  • Huntington’s Disease
  • Stroke
  • Traumatic brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Other Indications

Neurology Clinical Trials Market by Region:

  • North America Neurology Clinical Trials Market
  • Latin America Neurology Clinical Trials Market
  • Europe Neurology Clinical Trials Market
  • South Asia Neurology Clinical Trials Market
  • East Asia Neurology Clinical Trials Market
  • Oceania Neurology Clinical Trials Market
  • Middle East & Africa Neurology Clinical Trials Market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Mortuary Equipment Market Set to Solidify Global Presence with 5.8% CAGR from 2023 to 2033

Mortuary Equipment Market
Mortuary Equipment Market

In the dynamic landscape of healthcare equipment, the Mortuary Equipment Market is set to experience significant expansion between 2023 and 2033, with an average annual growth rate of 5.8%. Projections indicate that by 2033, the market will surge from its 2023 valuation of US$1,025.8 million to an impressive US$1,807.0 million, solidifying its position as a vital component of the worldwide industry.

A confluence of factors is propelling this growth trajectory. The ageing population, coupled with the expansion of healthcare facilities including hospitals and mortuaries, alongside shorter life spans and ongoing research and development initiatives, are driving up death rates and consequently fueling demand for mortuary equipment.

Automation is playing a pivotal role in augmenting the efficiency of mortuary processes such as body embalming, autopsy, storage, and relocation. With the integration of cutting-edge technology, modern mortuary equipment not only accelerates processing times but also enhances professional convenience, reflecting a transformative shift in the industry.

Get a Sample Copy of the Report:https://www.futuremarketinsights.com/reports/sample/rep-gb-14975

The impact of COVID-19 has also significantly influenced market dynamics. The pandemic has led to a surge in mortality rates across regions, amplifying the overall market size. For instance, between March 1, 2020, and June 30, 2020, Chennai, India, recorded a staggering 87,870 deaths. The urgent need to bolster mortuary infrastructure has resulted in substantial government investments and a growing demand for advanced mortuary equipment.

Automation is not just a matter of convenience but also addresses the challenges associated with working in mortuary environments. Automated equipment, such as moving and autopsy supplies, is witnessing increased adoption, driving global sales of mortuary equipment.

Furthermore, as populations expand, the incidence of fatalities rises, further underlining the importance of mortuary apparatus. Multicultural traditions also contribute to the demand for a comprehensive range of mortuary equipment, catering to diverse funeral practices worldwide.

In conclusion, the Mortuary Equipment Market is on an upward trajectory, fueled by demographic shifts, technological advancements, and evolving healthcare needs. As the industry continues to innovate and adapt, it is poised to play an increasingly crucial role in meeting the demands of a changing world.

In a comprehensive survey of the mortuary equipment market, regional analysis reveals promising trends across key global regions: North America, Latin America, Asia Pacific, Middle East and Africa (MEA), and Europe. The United States emerges as the largest and highest-growing market, boasting a robust CAGR of 5.3% from 2023 to 2033. By 2033, the U.S. market is anticipated to reach a noteworthy revenue of US$596.2 million.

The surge in demand for mortuary equipment in the United States is propelled by several factors, including the elevated mortality rate resulting from the COVID-19 pandemic, advancements in post-mortem technology, and the adoption of technologically advanced corpse storage systems.

Meanwhile, the Asia Pacific region stands out as the second-highest growing market for mortuary equipment. Within Asia Pacific, China’s market is experiencing rapid growth with a CAGR of 5.0%, while Japan follows closely with a similar CAGR. Projections indicate that by 2033, China’s market will reach a value of US$115.9 million, and Japan’s market will reach US$97.7 million.

In Europe, the United Kingdom (UK) demonstrates significant growth potential, forecasted to achieve US$74.1 million in market revenue by the end of 2033. The UK market thrives on a steady CAGR of 4.9% between 2023 and 2033, reflecting sustained demand for mortuary equipment within the region.

These regional insights underscore the global significance of mortuary equipment and highlight lucrative opportunities for market players across diverse geographical areas. As demand continues to rise driven by technological advancements and evolving healthcare needs, the mortuary equipment market is poised for sustained growth and innovation.

Recent Developments in the Mortuary Equipment Market

  • SM Scientific has completed its 50 years of service and has added new equipment like Body Display Cabinets, Organ Weighing Scale, and Evidence Drying Cabinet. This has pushed the demand for mortuary equipment in new regional spaces.
  • Leec Ltd has introduced its set of mortuary equipment like body storage, post-mortem spaces, dissecting, and organ weight calculator, pushing the demand for mortuary equipment in the country.

Key Players

  • SM Scientific Instruments Pvt. Ltd.
  • KUGEL medical GmbH & Co. KG
  • Leec Ltd
  • Thermo Fisher Scientific, Inc.
  • Mortech Manufacturing Company, Inc.

Key Segments

By Product:

  • Trolleys
  • Refrigeration Units
  • Autopsy Platforms and Equipment
  • Embalming Workstation
  • Dissection Table
  • Other Accessories

By Region:

  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Blood Banking Equipment Market Maintains Steady Growth with a 4.7% CAGR in the 2022 to 2032 Forecast

Blood Banking Equipment Market
Blood Banking Equipment Market

According to Future Market Insights, the value of the worldwide blood banking equipment market trends in 2021 will be US$ 14.2 billion. It is projected by the study that sales will increase at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2032 and surpass US$ 23.4 billion.

Hospitals and blood banks have long been concerned about the growing need for blood components brought on by an increase in surgeries and accidents. The previous few years have seen an increase in the number of procedures performed in the United Kingdom. 2019 saw the registration of almost 70,000 A&E cases nationwide. More supplies and equipment for blood banking will be needed as a result of the surgical procedures that these cases primarily require.

Increasing awareness about blood donation is the top priority of all blood transfusion centers. To address this issue, governments across the globe are offering several attractive reimbursement opportunities to volunteer donors.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14974

For instance, the AABB promotes full insurance coverage and offers lucrative reimbursement that will support the patients’ access to blood products, transfusion services and cellular therapies. The blood banking equipment market will witness immense growth in the upcoming years if such policies are implemented by developing economies as well.

The development of the blood banking equipment market is reliant on automation in blood bank centers, the rising trend of mobile blood drives/ camps, government support and initiatives and an increasing number of blood donors.

Key Takeaways

  • Blood collection products are expected to hold a 35.8% market value share in 2022 and are projected to display a CAGR growth of 4.8% over the forecast period.
  • Hospitals hold a higher share in the blood banking equipment market by a value of about 53.3% in 2021.
  • North America is slated to be the largest leading region with a value share of 26.2% at the end of the forecast period
  • India is expected to lead the growth in South Asia blood banking equipment market during the assessment period.

“Rising prevalence of chronic blood-related disorders, along with increasing trend of blood donation drives will fuel the blood banking equipment market over the forecast period,” says an analyst of Future Market Insights.

Market Competition

Acquisitions, partnerships, recognition and product launches are the key strategies adopted by manufacturers and integrators to increase the consumer base in different geographies.

  • Blood Collection: BD acquired Velano Vascular in July 2021 with the goal of adding breakthrough needle-free blood draw technology to alleviate the pain and discomfort of multiple needlesticks.
  • Blood Processing: The novel plasma collection system developed by Terumo Blood and Cell Technologies received FDA approval in March 2022. Rika is a next-generation automated system that focuses on plasma centre personnel and donors’ experiences. It has safety features to reduce operator mistakes and harvests plasma in under 35 minutes.

Want More Insights

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2032. The global blood banking equipment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the blood banking equipment market segment based on product– (blood collection [blood collection sets, blood bag tube sealer, blood collection mixer, blood bags, reagents, lancets, and others], blood processing [centrifuges, blood filters, blood bank analysers, blood warmers, and plasma thawing baths], blood storage [blood bank refrigerators, blood bank freezers, and test tube racks], and others), and end user (hospitals, and blood banks), across seven major regions.

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14974

Key Market Segments Covered in Blood Banking Equipment Industry Research

By Product:

  • Blood Collection
    • Blood Collection Sets
    • Blood Bag Tube Sealer
    • Blood Collection Mixer
    • Blood Bags
    • Reagents
    • Lancets
    • Others
  • Blood Processing
    • Centrifuges
    • Blood Filters
    • Blood Bank Analysers
    • Blood Warmers
    • Plasma Thawing Baths
  • Blood Storage
    • Blood Bank Refrigerators
    • Blood Bank Freezers
    • Test Tube Racks
  • Others

By End User:

  • Hospitals
  • Blood Banks

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Anti-counterfeit Pharmaceutical Packaging Market: Cost of Packaging on the Rise, Developing at a CAGR of 8.6% by 2033

Anti-counterfeit Pharmaceutical Packaging Market
Anti-counterfeit Pharmaceutical Packaging Market

Estimates suggest that the anti-counterfeit pharmaceutical packaging market will be worth US$ 108.1 billion by 2023. Projections indicate a substantial growth trajectory, with the market poised to soar to US$ 246.6 billion by 2033, boasting an impressive compound annual growth rate (CAGR) of 8.6%. This growth is attributed to the escalating need for enhanced security measures in the pharmaceutical industry to combat counterfeit drugs and ensure patient safety. As regulatory scrutiny intensifies and technological advancements continue to evolve, the demand for innovative anti-counterfeit packaging solutions is expected to surge, driving market expansion over the next decade.

The increasing emergence of new anti-counterfeiting technologies, such as edible micro tags can only be scanned through the utilization of the manufacturer’s proprietary equipment. It is also helping expand the global anti-counterfeit pharmaceutical packaging market.

Germany’s position as a leader in innovation and technology plays a pivotal role in the expected growth of the anti-counterfeit pharmaceutical packaging industry. With a projected market value of US$ 148.6 billion in 2023, Germany’s pharmaceutical packaging sector is set to thrive. This growth is primarily attributed to the nation’s robust commitment to technological advancements and its reputation for pioneering cutting-edge solutions.

Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-2385

The increasing prevalence of counterfeit pharmaceuticals poses a significant threat to public health. As awareness of this issue grows, pharmaceutical companies and regulatory bodies are taking strong measures to combat counterfeiting. It is done through advanced packaging solutions, which in turn drives the demand for anti-counterfeit pharmaceutical packaging.

Continuous advancements in anti-counterfeit technologies have made it feasible and cost-effective for pharmaceutical companies to implement robust security measures. Increasing strict regulation by governments and regulatory agencies for pharmaceutical packaging is likely to drive the market throughout the forecast period.

The growth of online pharmaceutical sales and e-commerce platforms has made it easy for counterfeit drugs to enter the market. E-commerce platforms are adopting anti-counterfeit packaging to protect consumers. The pharmaceutical industry’s continued growth and expansion into emerging markets are driving the need for anti-counterfeit measures.

Key Takeaways

  • From 2018 to 2022, the anti-counterfeit pharmaceutical packaging market demand expanded at a CAGR of 6%
  • Based on printing technology, the RFID segment is expected to account for a market share of 7.8% during the forecast period.
  • Global anti-counterfeit pharmaceutical packaging demand in the United Kingdom is predicted to account for a CAGR of 8.4% through 2033.
  • In the United States, the market is expected to account for a CAGR of 8.5% between 2023 and 2033.
  • China is projected to expand by a value CAGR of 8.3% through 2033.
  • By 2033, India’s anti-counterfeit pharmaceutical packaging market is anticipated to record a CAGR of 8.0%.

The increasing consumer awareness and expansion of the pharmaceutical industry globally is anticipated to drive the market growth during the forecast period.” says an FMI analyst.

Business Growth Drivers:

  1. Stringent Regulations: Increasing regulatory requirements and government initiatives aimed at combating counterfeit drugs have been a major driver. Regulatory bodies worldwide have mandated the implementation of anti-counterfeit measures to ensure patient safety and maintain the integrity of pharmaceutical products.
  2. Rising Incidences of Counterfeiting: With the growth of the pharmaceutical industry, the incidents of counterfeit drugs entering the market have also risen. This has propelled pharmaceutical companies to invest in robust anti-counterfeit packaging solutions to protect their products and brand reputation.
  3. Technological Advancements: Advances in anti-counterfeit technologies such as RFID (Radio Frequency Identification), barcoding, holograms, tamper-evident seals, and track-and-trace systems have made it easier for pharmaceutical companies to implement effective anti-counterfeit measures.
  4. Increasing Awareness: Growing awareness among consumers regarding the dangers associated with counterfeit drugs has driven the demand for secure packaging solutions. Patients are increasingly demanding assurances about the authenticity and safety of the medicines they consume, pushing pharmaceutical companies to invest in anti-counterfeit measures.
  5. Globalization of Pharmaceutical Supply Chains: The globalization of pharmaceutical supply chains has made them more vulnerable to counterfeiting. This has led to the adoption of comprehensive anti-counterfeit strategies to safeguard products throughout the supply chain, from manufacturing to distribution.

Industry Restraints:

  1. Cost of Implementation: One of the primary restraints is the cost associated with implementing anti-counterfeit measures. Pharmaceutical companies may find it challenging to justify the initial investment required for deploying sophisticated anti-counterfeit technologies, especially for smaller or generic drug manufacturers.
  2. Complexity and Integration Challenges: Integrating anti-counterfeit technologies into existing packaging processes can be complex and time-consuming. Pharmaceutical companies may face technical challenges in seamlessly integrating these solutions into their production lines without disrupting operations.
  3. Resistance to Change: Resistance to change within the industry can hinder the adoption of anti-counterfeit technologies. Some companies may be hesitant to invest in new technologies or upgrade existing systems due to concerns about disruptions, compatibility issues, or reluctance to depart from traditional packaging methods.
  4. Counterfeiters’ Innovation: Despite advancements in anti-counterfeit technologies, counterfeiters are also continually innovating their methods to bypass security measures. This ongoing cat-and-mouse game presents a challenge for pharmaceutical companies in staying ahead of counterfeiters and maintaining the efficacy of their anti-counterfeit strategies.
  5. Global Variability in Regulations: Regulatory requirements for anti-counterfeit measures vary across different regions and countries, leading to compliance challenges for multinational pharmaceutical companies. Navigating the complex regulatory landscape and ensuring compliance with diverse standards can be a significant restraint for companies operating in multiple markets.

Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-2385

Competitive Landscape

Leading anti-counterfeit pharmaceutical packaging manufacturers increasingly focus on expanding their product offerings to strengthen their customer base. They are adopting growth strategies such as new product launches, partnerships, acquisitions, mergers, collaborations, etc.  They expand their global footprint and gain a competitive edge in the market by following these strategies.

Some pharma companies have set up departments whose primary function is safeguarding their brand name from counterfeiting and illicit replication, raising the demand for anti-counterfeit pharmaceutical packaging.

  • IBM has been exploring the use of blockchain technology in pharmaceutical supply chains. They have collaborated with various pharmaceutical companies and regulatory bodies to create transparent and secure systems for tracking the provenance of pharmaceutical products
  • Systech offers serialization and traceability solutions for pharmaceutical companies. Their platform helps pharmaceutical manufacturers comply with track-and-trace regulations and provides real-time visibility into the supply chain.
  • Optel Group provides traceability and serialization solutions for the pharmaceutical industry. They have actively implemented track-and-trace systems to prevent counterfeit drugs from entering the supply chain.

Some of the key players in the global anti-counterfeit pharmaceutical packaging market are

  • Alien Technology
  • ATL Security Label Systems
  • CCL Industries
  • SICPA Holdings
  • Schott AG
  • Gerresheimer AG
  • Klockner Pentaplast Group
  • Ardagh Group S.A.
  • Nipro Corporation
  • Authentix Inc.
  • TruTag Technologies Inc.
  • Zebra Technologies Corporation
  • Alpvision SA
  • OpSec Security Inc.
  • Savi Technology Inc.
  • 3M
  • Stevanato Group.

Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/2385

Key Segmentations:

By Packaging Format :

  • Bottles & Jars
  • Vials & Ampoules
  • Blisters
  • Trays
  • Pouches & Sachets
  • Others (Tubes, Syringes, etc.)

By Printing Technology :

  • RFID
  • Security Inks & Coatings
  • Security Seals
  • Holograms
  • Mass Encryption
  • Barcode
  • Mass Serialization

By Adhesion :

  • Permanent
  • Removable
  • Repositionable

By End-application :

  • Pharma & Biological
  • Medical & Supplies
  • Gloves
  • Scissors
  • Syringes & Needles
  • Surgical Tapes
  • Others
  • Medical Equipment
  • Surgical
  • Therapeutic
  • Diagnostic

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Beverage Packaging Market: Sales Projection Indicates Anticipation of Reaching US$ 108.7 Billion by 2033

Beverage Packaging Market
Beverage Packaging Market

With a projected compound annual growth rate (CAGR) of 4.2%, the global beverage packaging market is set to achieve a valuation of US$ 164 billion by 2033. By 2023, the market is poised to reach US$ 108.7 billion, driven by initiatives aimed at incorporating environmentally friendly packaging alternatives and leveraging technological innovations. This growth trajectory reflects the industry’s commitment to sustainability and adaptation to changing consumer preferences. As beverage companies strive to reduce their carbon footprint and enhance product safety, the adoption of innovative packaging solutions is expected to play a pivotal role in shaping the market landscape over the coming years.

The beverage packaging market is experiencing substantial growth, fueled by various factors. One primary driver is the evolving preferences of consumers, leading to the adoption of packaging materials that enhance different aspects of beverage packaging.

Request Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-196

These materials are selected to improve properties such as strength, aroma retention, heat insulation, sealing, and moisture barriers, collectively contributing to the overall quality of the packaged beverage. There is a growing demand for smaller packaging formats, flexible bags, and pouches in the market. The integration of active and intelligent systems in beverage packaging is also boosting market growth, providing advanced features and functionalities.

The choice of packaging materials is a critical factor in the beverage packaging market. Various materials, such as glass, polymers, metals, and paperboard, are combined based on the chemical composition and value of the beverage. This diversity allows beverage manufacturers to select the most suitable option for their products, considering factors like extending shelf life and preserving beverage quality.

Several macroeconomic factors are positively influencing the growth of the beverage packaging market. The increasing global population and changing lifestyles are driving demand for convenient and efficient packaging technologies. Consumers, with rising disposable incomes, are inclined towards premium products.

The prominence of PET (polyethylene terephthalate) material as a popular choice for packaging raw materials is noteworthy. The transition from unpackaged to packaged products, particularly in emerging economies, presents lucrative opportunities for players in the beverage packaging market.

Business Drivers:

  1. Innovation and Sustainability:
    • Growing consumer demand for sustainable packaging solutions has led to increased innovation in eco-friendly materials and designs.
    • Companies are adopting recycled and recyclable materials to reduce environmental impact.
  2. Convenience and Portability:
    • The demand for on-the-go and convenient packaging options continues to drive innovation in lightweight and easy-to-carry beverage packaging.
  3. Health and Wellness Trends:
    • Rising awareness of health and wellness has influenced the demand for packaging that preserves the nutritional content of beverages while providing information about ingredients and benefits.
  4. Brand Differentiation:
    • Packaging plays a crucial role in brand differentiation. Companies invest in unique and visually appealing packaging to stand out on the shelves and attract consumers.
  5. E-commerce Growth:
    • The increasing popularity of online shopping has driven the need for robust and protective packaging solutions to ensure the safe delivery of beverages.

Market Restraints:

  1. Costs and Economic Factors:
    • Fluctuations in raw material prices and economic challenges can impact production costs, affecting the overall profitability of beverage packaging.
  2. Environmental Concerns:
    • While sustainability is a driver, there are also challenges in finding cost-effective and truly sustainable alternatives. Balancing environmental concerns with economic viability can be a restraint.
  3. Supply Chain Disruptions:
    • Disruptions in the supply chain, as seen during global events or natural disasters, can impact the availability and cost of packaging materials.
  4. Changing Consumer Preferences:
    • Rapid shifts in consumer preferences can pose challenges for manufacturers who must adapt packaging designs and materials to meet evolving demands.
  5. Stringent Regulations:
    • While regulatory compliance is a driver, overly strict regulations or sudden changes in standards can pose challenges for businesses in terms of adaptation and cost.

Key Takeaways from the Market Study

  • The market in 2022 was valued at US$ 3 billion.
  • The valuation of the market in 2018 was US$ 96.7 billion.
  • Based on product type, liquid cartons are likely to register a market share of 35.2% by 2023.
  • The beverage packaging market size expanded at a 1.9% CAGR between 2018 and 2022.
  • India is expected to lead the market, expected to register a 6.1% CAGR until 2033.
  • By application, beverage packaging for non-alcoholic drinks is expected to accumulate a 54.7% revenue share in 2023.

“Stringent governmental regulations addressing packaging waste and decomposition are considered one of the key restraints of the beverage packaging market,” comments a Future Market Insights analyst.

Request Report Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-196

Competitive Landscape

The sector possesses a considerable assortment of market contributors. Innovation and research assume a crucial role among these entities, primarily emphasizing incorporating environmentally sustainable product ranges as a fundamental element of their production initiatives.

Key players deploy various expansion tactics, such as partnerships, corporate mergers and acquisitions, and thorough examination of regulatory authorizations, to reinforce their foothold in the market.

The Major Key Players Are:

  • Crown Holdings Inc.
  • Amcor Limited
  • Ardagh Group S.A
  • Ball Corporation
  • Gerresheimer AG
  • Owens-Illinois Inc.
  • Berry Global Inc.
  • Beatson Clark Ltd.
  • Intrapac International Corporation
  • BA Glass Germany GmbH
  • Nampak Ltd.
  • Vidrala S.A
  • Silgan Containers LLC
  • Orora Packaging Australia Pty Ltd.

Key Developments

  • In September 2022, a deal worth US$ 530 million was successfully concluded between Ball Corp and Arnest Group, involving the beverage packaging business in Russia. Following Russia’s invasion of Ukraine in March, the sustainable metal packaging manufacturer downsized its operations, including five production facilities in Russia.
  • In October 2022, Berry Global continuously innovated and invested in working toward the world goal of a net-zero economy. As an industry leader, efforts were made to reduce greenhouse gas emissions and increase renewable energy uses

Buy Now/Purchase: https://www.futuremarketinsights.com/checkout/196

Key Segmentations-

By Product Type:

  • Liquid Cartons
  • Beverage Cans
  • Glass Bottles
  • Plastic Bottles
  • Others

By Material:

  • Glass
  • Plastic
  • HDPE
  • LDPE
  • PET
  • PP
  • Metal
  • Paper/Paperboard

By Application:

  • Alcoholic Drinks
  • Beer
  • Wine
  • Spirits
  • Other Alcoholic Beverages
  • Non-Alcoholic Drinks
  • Fruit Juices
  • Carbonated Drinks/Soda
  • RTD Beverages
  • Bottled Water
  • Tea & Coffee
  • Milk Products
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube